1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Market Coverage Market Overview Product Offerings 6. Market Landscape 6.1. Market Size 6.2. Market Forecast 6.3. Five Force Analysis 7. Geographical Segmentation 8. Key Leading Countries USA Germany Japan 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 16.1. Baxter International Inc. 16.1.1. Business Overview 16.1.2. Business Segmentation 16.1.3. SWOT Analysis 16.2. DePuy Inc. 16.2.1. Business Overview 16.2.2. Business Segmentation 16.2.3. Key Information 16.2.4. SWOT Analysis 16.3. Medtronic Inc. 16.3.1. Business Overview 16.3.2. Business Segmentation 16.3.3. SWOT Analysis 16.4. Stryker Corp. 16.4.1. Business Overview 16.4.2. Business Segmentation 16.4.3. Key Information 16.4.4. SWOT Analysis 16.5. Zimmer Holdings Inc. 16.5.1. Business Overview 16.5.2. Business Segmentation 16.5.3. Key Information 16.5.4. SWOT Analysis 17. Other Reports in this Series List of Exhibits: Exhibit 1: Global Stem Cell Products Market 2012–2016 (US$ billion) Exhibit 2: Stem Cell Products Market in the Americas 2012–2016 (US$ billion) Exhibit 3: Stem Cell Products Market in the APAC Region 2012–2016 (US$ billion) Exhibit 4: Stem Cell Products Market in the EMEA Region 2012–2016 (US$ billion) Exhibit 5: Global Stem Cell Products Market by Geographical Segmentation 2012 Exhibit 6: Business Segmentation of Baxter International Inc. Exhibit 7: Business Segmentation of DePuy Inc. Exhibit 8: Business Segmentation of Medtronic Inc. Exhibit 9: Business Segmentation of Stryker Corp. Exhibit 10: Business Segmentation of Zimmer Holdings Inc.

Baxter International Inc., DePuy Inc., Medtronic Inc., Stryker Corp., Zimmer Holdings Inc.,3DM Inc., Aastrom Biosciences Inc., Advanced Cell Technology Inc., Aldagen Inc., Angioblast Systems Inc., Arteriocyte Inc., Athersys Inc., BioE Corp., Bioheart Inc., BioTime Inc., Brainstorm Cell Therapeutics Inc., Capricor Inc., Cardio3 BioSciences SA, Cellartis AB, Cellerant Therapeutics Inc., Cellular Dynamics International Inc., Cytori Therapeutics Inc., Forticell Bioscience Inc., Gamida Cell Ltd., GlobalStem Inc., Hybrid Organ GmbH, IntelliCell BioSciences Inc., International Stem Cell Corp., Juventas Therapeutics Inc., Medistem Inc., Mesoblast Ltd., NeoStem Inc., Neuralstem Inc., Osiris Therapeutics Inc., PharmaStem Therapeutics Inc., Plureon Corp., ReNeuron Group plc, RhinoCyte Inc., StemCells Inc., Stemcell Technologies SARL, Stem Cell Therapeutics Corp., Stemedica Cell Technologies Inc., Stemina Biomarker Discovery Inc., TiGenix NV, Verastem Inc., ViaCyte Inc., and Vitro Diagnostics Inc.